PGL PHARMA

Aywaille ·KBO/BCE: BE 0764.558.948

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	30-04-2026	92 d early	2026-00097382
31-12-2024	31-07-2025	04-07-2025	27 d early	2025-00233060
31-12-2023	31-07-2024	26-07-2024	5 d early	2024-00290382
31-12-2022	31-07-2023	30-06-2023	31 d early	2023-00190215

Metric	This company	Sector median	Position in the sector
Solvency	23.3%	42.2%	better than 31% of 297 sector peers
Net result	€47k	€57k	better than 45% of 296 sector peers
Equity	€226k	€207k	better than 51% of 297 sector peers
Gross operating margin	€69k	€83k	better than 43% of 247 sector peers
Total assets	€970k	€690k	better than 55% of 297 sector peers

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€970k
Fixed assets	21/28	€931k
Financial fixed assets	28	€931k
Current assets	29/58	€39k
Amounts receivable within one year	40/41	€33k
Cash & bank	54/58	€6k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€970k
Equity	10/15	€226k
Contributions / capital	10/11	€45k
Reserves	13	€180k
Accumulated profits (losses)	14	€1k
Amounts payable	17/49	€744k
Amounts payable after one year	17	€341k
Amounts payable within one year	42/48	€402k
Trade debts payable within one year	44	€1k
Income statement
Gross operating margin	9900	€69k
Operating result	9901	€69k
Financial charges	65	€5k
Result before taxes	9903	€64k
Income taxes	67/77	€16k
Net result for the period	9904	€47k
Result to be appropriated	9905	€47k

Summary